Gilman Hill Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,750
Closed -$212K 163
2020
Q2
$212K Hold
2,750
0.08% 151
2020
Q1
$206K Sell
2,750
-1,250
-31% -$86.4K 0.1% 145
2019
Q4
$260K Hold
4,000
0.08% 149
2019
Q3
$254K Buy
4,000
+225
+6% +$14.7K 0.08% 157
2019
Q2
$255K Sell
3,775
-1,550
-29% -$102K 0.09% 156
2019
Q1
$346K Buy
+5,325
New +$354K 0.12% 135
2018
Q4
Sell
-3,575
Closed -$276K 179
2018
Q3
$276K Sell
3,575
-775
-18% -$58.5K 0.11% 140
2018
Q2
$308K Buy
+4,350
New +$307K 0.13% 136
2017
Q3
Sell
-3,250
Closed -$230K 174
2017
Q2
$230K Buy
+3,250
New +$216K 0.1% 150
2017
Q1
Sell
-4,157
Closed -$298K 166
2016
Q4
$298K Buy
4,157
+1,250
+43% +$92.9K 0.11% 139
2016
Q3
$230K Sell
2,907
-53
-2% -$4.3K 0.09% 158
2016
Q2
$247K Buy
2,960
+92
+3% +$8.16K 0.1% 142
2016
Q1
$263K Hold
2,868
0.12% 136
2015
Q4
$290K Hold
2,868
0.14% 129
2015
Q3
$282K Hold
2,868
0.15% 119
2015
Q2
$336K Hold
2,868
0.16% 115
2015
Q1
$281K Sell
2,868
-250
-8% -$25.4K 0.13% 126
2014
Q4
$294K Buy
3,118
+53
+2% +$5.48K 0.15% 120
2014
Q3
$326K Sell
3,065
-750
-20% -$73.4K 0.18% 106
2014
Q2
$316K Sell
3,815
-60
-2% -$4.67K 0.16% 109
2014
Q1
$275K Sell
3,875
-215
-5% -$16.9K 0.16% 107
2013
Q4
$307K Sell
4,090
-125
-3% -$8.7K 0.2% 87
2013
Q3
$265K Buy
4,215
+90
+2% +$5.38K 0.19% 83
2013
Q2
$211K Buy
+4,125
New +$215K 0.15% 95

Other funds holding GILD

Gilman Hill Asset Management's GILD Position: Q3 2020 in Review

Gilman Hill Asset Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,750 shares — an estimated $212K sold.

Gilman Hill Asset Management first reported a position in GILD in Q2 2013 and held it in 24 quarters. The position peaked at $346K in Q1 2019. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Gilman Hill Asset Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Gilman Hill Asset Management sold 2,750 Gilead Sciences shares in Q3 2020, an estimated $212K.
  • Gilman Hill Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 24 quarters.
  • Gilman Hill Asset Management's Gilead Sciences position peaked at $346K in Q1 2019.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Gilman Hill Asset Management's 13F filing for Q3 2020, filed 16 Oct 2020.